I don't know if-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

A.a
01-10 11:18

I don't know if

One-week Hong Kong stock bull and bear list | Pharmaceutical stocks carnival at the beginning of the year, Jinfang Pharmaceutical rose 45% for the week; Jingtai Holdings and Insilicon Intelligent rose 25% weekly; Sunac China, Hongteng Precision fell 11%

总结全周， $恒生指数$ 跌106点或0.41%， $恒生科技指数$ 跌49点或0.86%；本周市值百亿以上、日均成交千万以上表现最好五只股票是 $劲方医药-B$ 、 $量化派$ 、 $荣昌生物$ 、$晶泰控股$ 、$英矽智能$ ；表现最差的五只股票是 $云知声$ 、 $融创中国$、 $鸿腾精密$ 、$汇聚科技$ 、$环球新材国际$ 。重点关注创新药产业链，景气度预计将持续向上。新年第一个完整周，英矽智能升25.07%。本公司亦已取得联交所批准换股股份上市及买卖。

One-week Hong Kong stock bull and bear list | Pharmaceutical stocks carnival at the beginning of the year, Jinfang Pharmaceutical rose 45% for the week; Jingtai Holdings and Insilicon Intelligent rose 25% weekly; Sunac China, Hongteng Precision fell 11%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":520109275783960,"tweetId":"520109275783960","gmtCreate":1768015092792,"gmtModify":1768015235218,"author":{"id":4230864351453372,"idStr":"4230864351453372","authorId":4230864351453372,"authorIdStr":"4230864351453372","name":"A.a","avatar":"https://community-static.tradeup.com/news/389e959f7198c5ce899c5c12271a7d48","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>I don't know if&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>I don't know if&nbsp;</p></body></html>","text":"I don't know if","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/520109275783960","repostId":1168058667,"repostType":2,"repost":{"id":"1168058667","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1767950551,"share":"https://ttm.financial/m/news/1168058667?lang=en_US&edition=fundamental","pubTime":"2026-01-09 17:22","market":"hk","language":"zh","title":"One-week Hong Kong stock bull and bear list | Pharmaceutical stocks carnival at the beginning of the year, Jinfang Pharmaceutical rose 45% for the week; Jingtai Holdings and Insilicon Intelligent rose 25% weekly; Sunac China, Hongteng Precision fell 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168058667","media":"老虎资讯综合","summary":"总结全周， $恒生指数$ 跌106点或0.41%， $恒生科技指数$ 跌49点或0.86%；本周市值百亿以上、日均成交千万以上表现最好五只股票是 $劲方医药-B$ 、 $量化派$ 、 $荣昌生物$  、$晶泰控股$  、$英矽智能$ ；表现最差的五只股票是 $云知声$ 、 $融创中国$、  $鸿腾精密$  、$汇聚科技$  、$环球新材国际$ 。重点关注创新药产业链，景气度预计将持续向上。新年第一个完整周，英矽智能升25.07%。本公司亦已取得联交所批准换股股份上市及买卖。","content":"<p><html><head></head><body><ul style=\"\"><li>Summarize the whole week (January 5th-January 9th),<a href=\"https://laohu8.com/S/HSI\">Hang Seng Index</a>Down 106 points or 0.41%,<a href=\"https://laohu8.com/S/HSTECH\">Hang Seng Technology Index</a>Down 49 points or 0.86%;</p><p></li><li>The five best stocks with a market value of more than 10 billion and an average daily turnover of more than 10 million this week are<a href=\"https://laohu8.com/S/02595\">Jinfang Pharmaceutical-B</a>、<a href=\"https://laohu8.com/S/02685\">Quantitative school</a>、<a href=\"https://laohu8.com/S/09995\">Rongchang Biotech</a>、<a href=\"https://laohu8.com/S/02228\">Jingtai Holdings</a>、<a href=\"https://laohu8.com/S/03696\">Insilicon Smart</a>；</p><p></li><li>The five worst performing stocks are<a href=\"https://laohu8.com/S/09678\">Yun Zhisheng</a>、<a href=\"https://laohu8.com/S/01918\">Sunac China</a>、<a href=\"https://laohu8.com/S/06088\">Hongteng Precision</a>、<a href=\"https://laohu8.com/S/01729\">Gathering Technology</a>、<a href=\"https://laohu8.com/S/06616\">Global New Materials International</a>。</p><p></li></ul><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2d35f50a8b9c930c98d647866de1e9d8\" tg-width=\"1080\" tg-height=\"1715\"/></p><p><h2 id=\"id_2539767564\">1. Analysis of the top gainers</h2><h3 id=\"id_2804113095\">2595. HK Jinfang Pharmaceutical-B (+44.85%)/9995. HK Rongchang Biotech (+28.51%)</h3>From the perspective of catalysis, there have been frequent benefits in the pharmaceutical field since the beginning of the year. In terms of innovative drug research and development, the CTLA-4 monoclonal antibody \"Daboxin\" independently developed by Innovent Biologics was approved for marketing in China, filling the gap in the field of dual immune neoadjuvant therapy in China; In terms of BD, Garcos and AstraZeneca have reached a cooperation of over US $2 billion, setting a domestic record for small molecule anticancer drug cooperation in the clinical stage. In terms of medical care, Musk said that brain-computer interface equipment will be \"mass-produced\".</p><p><p style=\"text-align: justify;\">In addition, brokerages are intensively bullish or further boost their enthusiasm for doing more pharmaceuticals. The latest research reports of securities firms such as Pacific Securities, Cathay Pacific Haitong, and Industrial Securities all stated that they will continue to focus on recommending innovative pharmaceutical equipment industry chains.</p><p><p style=\"text-align: justify;\">Regarding the strategy of the pharmaceutical sector, Industrial Securities believes that \"innovation + internationalization\" will remain the core main line of the sector in 2026. Focus on innovative drugs whose industry trends continue to improve, and global competitiveness continues to be strengthened + going overseas continues to be implemented + commercialization profits are realized. Focus on the innovative drug industry chain, and the prosperity is expected to continue to rise. At the same time, the influencing factors of the medical device industry continue to ease, innovation and internationalization are accelerating, and it is expected to usher in improvement in 2026. In addition, if consumer sentiment improves, consumer medical care (medical services, traditional Chinese medicine OTC and chain pharmacies, etc.) is expected to enter the recovery stage.</p><p><h3 id=\"id_3710354098\">2685. HK Quant (+29.97%)</h3>Quantitative School landed on the Hong Kong Stock Exchange on November 27 last year, and its current price has increased by 257.55% compared with the IPO price of HK $9.8.</p><p><p style=\"text-align: start;\">According to public information, Quantitative School was established in 2014. As an online market operator focusing on China's consumer field, it operates the consumer e-commerce platform \"Yangxiaomei\" and the automobile retail O2O platform \"Consumer Map\" to assist business partners in matching goods and services with end consumers.</p><p><p style=\"text-align: start;\">Quantitative's Yangxiaomei platform has covered a variety of retail products since November 2020, such as consumer electronics products, food and beverages, home appliances, cosmetics, jewelry, clothing and personal daily care products provided by third-party market suppliers, and Match these consumer products with the company's Yangxiaomei users through online purchases.</p><p><p style=\"text-align: start;\">Quantitative Pai has operated the consumption map of the automobile retail O2O platform since April 2022. Currently, it mainly cooperates with automobile retailers to attract online traffic, allowing them to buy cars offline in local physical stores. To a lesser extent, the consumption map can also allow consumers to buy a car online. In addition, Quantitative School also provides advertising services for business partners.</p><p><h3 id=\"id_1875387013\">2228. HK Jingtai Holdings (+25.53%)</h3>In terms of news, JinkoSolar recently announced that it has signed a strategic cooperation agreement with Jingtai Technology. The two parties will jointly establish a joint venture to promote the cooperative research and development of high-throughput perovskite stacked solar cells based on AI technology. This move marks the official launch of in-depth collaboration between the two companies in the fields of next-generation photovoltaic technologies such as perovskite stacks, aiming to reshape the photovoltaic R&D model through \"AI + robots\" and accelerate the R&D and industrialization process of disruptive technologies.</p><p><p style=\"text-align: start;\">In addition, Jingtai Holdings announced that it proposes to issue 2.866 billion yuan of zero-coupon convertible bonds due in 2027. The initial conversion price is HK $13.85 per share, which is a premium of approximately 20% over the closing price of HK $11.54 on January 7. It can be fully converted into 207 million shares, accounting for approximately 4.59% of the enlarged share capital. The proceeds are intended to be used to enhance the company's domestic and international R&D capabilities and one-stop solution provision capabilities; Enhance domestic and international commercialization capabilities and expand business development and marketing teams; Expand domestic and international delivery and R&D capabilities through the construction of factories; Working capital and general corporate purposes.</p><p><h3 id=\"id_1220499714\">3696. HK Insilicon (+25.07%)</h3>At the end of 2025, Insilicon Intelligent landed on the Hong Kong Stock Exchange, won the title of \"the first AI pharmaceutical stock in Hong Kong stocks\", and shocked the market with a 45.53% surge on the first day. A few days after its listing, the company announced that it had reached a multi-year anti-tumor drug research and development cooperation with Servier worth US $888 million, targeting \"challenging targets\" in the anti-tumor field.</p><p><p style=\"text-align: start;\">This series of events once again pushed the issue of \"how artificial intelligence subverts traditional drug research and development\" into the spotlight. The market reacted enthusiastically.</p><p>In the first full week of the new year, Insilicon rose 25.07%.</p><p><h2 id=\"id_3980243290\">2. Analysis of stocks with the top declines</h2><h3 id=\"id_3682739675\">1918. HK Sunac China (-11.72%)</h3>Sunac China announced that the cumulative contracted sales amount last year was approximately 36.84 billion yuan (RMB ‧ the same below), a year-on-year decrease of 21.85%; The cumulative contracted sales area was approximately 1.453 million square meters, a year-on-year decrease of 35.74%; The average contract sales price is about 25,350 yuan per square meter.</p><p>In December last year alone, the contracted sales amount was about 2.95 billion yuan, a year-on-year increase of 68.57%; The contracted sales area was approximately 272,000 square meters, a year-on-year increase of 97.1%; The average contract sales price is about 10,850 yuan per square meter.</p><p><h3 id=\"id_2764955112\">6088. HK Hongteng Precision (-11.35%)</h3>Hongteng Precision announced that since yesterday (1st), it has chosen an alternative threshold instead of the initial designated threshold, that is, the part of the share class listed on the Stock Exchange held by the public at any time must reach a market value of at least 1 billion yuan and account for at least 10% of the total number of issued shares (excluding treasury shares) of the issuer in this class, so as to meet the minimum public float stipulated in Rule 13.32 B of the Listing Rules.</p><p>Taking into account the Company's shareholding structure, historical trading liquidity and overall circumstances, the Board considers that the alternative threshold is appropriate and therefore in the interests of the Company and its shareholders as a whole.</p><p><h3 id=\"id_2495436243\">1729. HK Convergence Technology (-11.09%)</h3>Convergence Technology (01729) announced that on January 2, 2026, the company issued 10,000 shares according to the share plan.</p><p><h3 id=\"id_1847704986\">6616. HK Global New Materials International (-10.26%)</h3>Global New Materials International announced that all the conditions precedent set out in the subscription agreement have been fulfilled, and the issuance of convertible bonds with a total principal amount of HK $1 billion will be completed on January 6, 2026.</p><p><p style=\"text-align: start;\">The Convertible Bonds have been listed on Vienna MTF, which is operated by the Vienna Stock Exchange, since 6 January 2026. The Company has also obtained the approval from the Stock Exchange for the listing of and permission to deal in the Conversion Shares.</p><p></body></html></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One-week Hong Kong stock bull and bear list | Pharmaceutical stocks carnival at the beginning of the year, Jinfang Pharmaceutical rose 45% for the week; Jingtai Holdings and Insilicon Intelligent rose 25% weekly; Sunac China, Hongteng Precision fell 11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne-week Hong Kong stock bull and bear list | Pharmaceutical stocks carnival at the beginning of the year, Jinfang Pharmaceutical rose 45% for the week; Jingtai Holdings and Insilicon Intelligent rose 25% weekly; Sunac China, Hongteng Precision fell 11%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2026-01-09 17:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body><ul style=\"\"><li>Summarize the whole week (January 5th-January 9th),<a href=\"https://laohu8.com/S/HSI\">Hang Seng Index</a>Down 106 points or 0.41%,<a href=\"https://laohu8.com/S/HSTECH\">Hang Seng Technology Index</a>Down 49 points or 0.86%;</p><p></li><li>The five best stocks with a market value of more than 10 billion and an average daily turnover of more than 10 million this week are<a href=\"https://laohu8.com/S/02595\">Jinfang Pharmaceutical-B</a>、<a href=\"https://laohu8.com/S/02685\">Quantitative school</a>、<a href=\"https://laohu8.com/S/09995\">Rongchang Biotech</a>、<a href=\"https://laohu8.com/S/02228\">Jingtai Holdings</a>、<a href=\"https://laohu8.com/S/03696\">Insilicon Smart</a>；</p><p></li><li>The five worst performing stocks are<a href=\"https://laohu8.com/S/09678\">Yun Zhisheng</a>、<a href=\"https://laohu8.com/S/01918\">Sunac China</a>、<a href=\"https://laohu8.com/S/06088\">Hongteng Precision</a>、<a href=\"https://laohu8.com/S/01729\">Gathering Technology</a>、<a href=\"https://laohu8.com/S/06616\">Global New Materials International</a>。</p><p></li></ul><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/2d35f50a8b9c930c98d647866de1e9d8\" tg-width=\"1080\" tg-height=\"1715\"/></p><p><h2 id=\"id_2539767564\">1. Analysis of the top gainers</h2><h3 id=\"id_2804113095\">2595. HK Jinfang Pharmaceutical-B (+44.85%)/9995. HK Rongchang Biotech (+28.51%)</h3>From the perspective of catalysis, there have been frequent benefits in the pharmaceutical field since the beginning of the year. In terms of innovative drug research and development, the CTLA-4 monoclonal antibody \"Daboxin\" independently developed by Innovent Biologics was approved for marketing in China, filling the gap in the field of dual immune neoadjuvant therapy in China; In terms of BD, Garcos and AstraZeneca have reached a cooperation of over US $2 billion, setting a domestic record for small molecule anticancer drug cooperation in the clinical stage. In terms of medical care, Musk said that brain-computer interface equipment will be \"mass-produced\".</p><p><p style=\"text-align: justify;\">In addition, brokerages are intensively bullish or further boost their enthusiasm for doing more pharmaceuticals. The latest research reports of securities firms such as Pacific Securities, Cathay Pacific Haitong, and Industrial Securities all stated that they will continue to focus on recommending innovative pharmaceutical equipment industry chains.</p><p><p style=\"text-align: justify;\">Regarding the strategy of the pharmaceutical sector, Industrial Securities believes that \"innovation + internationalization\" will remain the core main line of the sector in 2026. Focus on innovative drugs whose industry trends continue to improve, and global competitiveness continues to be strengthened + going overseas continues to be implemented + commercialization profits are realized. Focus on the innovative drug industry chain, and the prosperity is expected to continue to rise. At the same time, the influencing factors of the medical device industry continue to ease, innovation and internationalization are accelerating, and it is expected to usher in improvement in 2026. In addition, if consumer sentiment improves, consumer medical care (medical services, traditional Chinese medicine OTC and chain pharmacies, etc.) is expected to enter the recovery stage.</p><p><h3 id=\"id_3710354098\">2685. HK Quant (+29.97%)</h3>Quantitative School landed on the Hong Kong Stock Exchange on November 27 last year, and its current price has increased by 257.55% compared with the IPO price of HK $9.8.</p><p><p style=\"text-align: start;\">According to public information, Quantitative School was established in 2014. As an online market operator focusing on China's consumer field, it operates the consumer e-commerce platform \"Yangxiaomei\" and the automobile retail O2O platform \"Consumer Map\" to assist business partners in matching goods and services with end consumers.</p><p><p style=\"text-align: start;\">Quantitative's Yangxiaomei platform has covered a variety of retail products since November 2020, such as consumer electronics products, food and beverages, home appliances, cosmetics, jewelry, clothing and personal daily care products provided by third-party market suppliers, and Match these consumer products with the company's Yangxiaomei users through online purchases.</p><p><p style=\"text-align: start;\">Quantitative Pai has operated the consumption map of the automobile retail O2O platform since April 2022. Currently, it mainly cooperates with automobile retailers to attract online traffic, allowing them to buy cars offline in local physical stores. To a lesser extent, the consumption map can also allow consumers to buy a car online. In addition, Quantitative School also provides advertising services for business partners.</p><p><h3 id=\"id_1875387013\">2228. HK Jingtai Holdings (+25.53%)</h3>In terms of news, JinkoSolar recently announced that it has signed a strategic cooperation agreement with Jingtai Technology. The two parties will jointly establish a joint venture to promote the cooperative research and development of high-throughput perovskite stacked solar cells based on AI technology. This move marks the official launch of in-depth collaboration between the two companies in the fields of next-generation photovoltaic technologies such as perovskite stacks, aiming to reshape the photovoltaic R&D model through \"AI + robots\" and accelerate the R&D and industrialization process of disruptive technologies.</p><p><p style=\"text-align: start;\">In addition, Jingtai Holdings announced that it proposes to issue 2.866 billion yuan of zero-coupon convertible bonds due in 2027. The initial conversion price is HK $13.85 per share, which is a premium of approximately 20% over the closing price of HK $11.54 on January 7. It can be fully converted into 207 million shares, accounting for approximately 4.59% of the enlarged share capital. The proceeds are intended to be used to enhance the company's domestic and international R&D capabilities and one-stop solution provision capabilities; Enhance domestic and international commercialization capabilities and expand business development and marketing teams; Expand domestic and international delivery and R&D capabilities through the construction of factories; Working capital and general corporate purposes.</p><p><h3 id=\"id_1220499714\">3696. HK Insilicon (+25.07%)</h3>At the end of 2025, Insilicon Intelligent landed on the Hong Kong Stock Exchange, won the title of \"the first AI pharmaceutical stock in Hong Kong stocks\", and shocked the market with a 45.53% surge on the first day. A few days after its listing, the company announced that it had reached a multi-year anti-tumor drug research and development cooperation with Servier worth US $888 million, targeting \"challenging targets\" in the anti-tumor field.</p><p><p style=\"text-align: start;\">This series of events once again pushed the issue of \"how artificial intelligence subverts traditional drug research and development\" into the spotlight. The market reacted enthusiastically.</p><p>In the first full week of the new year, Insilicon rose 25.07%.</p><p><h2 id=\"id_3980243290\">2. Analysis of stocks with the top declines</h2><h3 id=\"id_3682739675\">1918. HK Sunac China (-11.72%)</h3>Sunac China announced that the cumulative contracted sales amount last year was approximately 36.84 billion yuan (RMB ‧ the same below), a year-on-year decrease of 21.85%; The cumulative contracted sales area was approximately 1.453 million square meters, a year-on-year decrease of 35.74%; The average contract sales price is about 25,350 yuan per square meter.</p><p>In December last year alone, the contracted sales amount was about 2.95 billion yuan, a year-on-year increase of 68.57%; The contracted sales area was approximately 272,000 square meters, a year-on-year increase of 97.1%; The average contract sales price is about 10,850 yuan per square meter.</p><p><h3 id=\"id_2764955112\">6088. HK Hongteng Precision (-11.35%)</h3>Hongteng Precision announced that since yesterday (1st), it has chosen an alternative threshold instead of the initial designated threshold, that is, the part of the share class listed on the Stock Exchange held by the public at any time must reach a market value of at least 1 billion yuan and account for at least 10% of the total number of issued shares (excluding treasury shares) of the issuer in this class, so as to meet the minimum public float stipulated in Rule 13.32 B of the Listing Rules.</p><p>Taking into account the Company's shareholding structure, historical trading liquidity and overall circumstances, the Board considers that the alternative threshold is appropriate and therefore in the interests of the Company and its shareholders as a whole.</p><p><h3 id=\"id_2495436243\">1729. HK Convergence Technology (-11.09%)</h3>Convergence Technology (01729) announced that on January 2, 2026, the company issued 10,000 shares according to the share plan.</p><p><h3 id=\"id_1847704986\">6616. HK Global New Materials International (-10.26%)</h3>Global New Materials International announced that all the conditions precedent set out in the subscription agreement have been fulfilled, and the issuance of convertible bonds with a total principal amount of HK $1 billion will be completed on January 6, 2026.</p><p><p style=\"text-align: start;\">The Convertible Bonds have been listed on Vienna MTF, which is operated by the Vienna Stock Exchange, since 6 January 2026. The Company has also obtained the approval from the Stock Exchange for the listing of and permission to deal in the Conversion Shares.</p><p></body></html></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","relate_stocks":{"02685":"量化派","02595":"劲方医药-B","09678":"云知声","09995":"荣昌生物","02228":"晶泰控股","06616":"环球新材国际","03696":"英矽智能","06088":"鸿腾精密","01729":"汇聚科技","01918":"融创中国"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168058667","content_text":"总结全周（1月5日-1月9日）， 恒生指数 跌106点或0.41%， 恒生科技指数 跌49点或0.86%；本周市值百亿以上、日均成交千万以上表现最好五只股票是 劲方医药-B 、 量化派 、 荣昌生物  、晶泰控股  、英矽智能 ；表现最差的五只股票是 云知声 、 融创中国、  鸿腾精密  、汇聚科技  、环球新材国际 。一、涨幅居前个股解析2595.HK 劲方医药-B (+44.85%) / 9995.HK 荣昌生物 (+28.51%)从催化来看，开年来医药领域利好频出。创新药研发方面，信达生物自主研发的CTLA-4单抗“达伯欣”国产获批上市，填补了国内双免疫新辅助疗法领域的空白；BD方面，加科思与阿斯利康达成超20亿美元合作，创国内临床阶段小分子抗癌药合作纪录。医疗方面，马斯克放话脑机接口设备将“大规模生产”。此外，券商密集看多或进一步推升医药做多热情。太平洋证券、国泰海通、兴业证券等券商最新研报均表示，持续重点推荐创新药械产业链。就医药板块策略，兴业证券认为，“创新+国际化”仍将是2026年板块核心主线。重点关注产业趋势持续向好的创新药，全球竞争力持续加强+出海持续落地+商业化盈利兑现。重点关注创新药产业链，景气度预计将持续向上。同时，医疗器械行业影响因素持续缓和，创新与国际化加速推进，2026年有望迎来改善。此外，若消费情绪出现改善，消费医疗（医疗服务、中药OTC与连锁药店等）有望进入复苏阶段。2685.HK 量化派 (+29.97%)量化派于去年11月27日登陆港交所，现价较IPO价格9.8港元已经累涨257.55%。公开资料显示，量化派成立于2014年，作为一家专注于中国消费领域的在线市场营运商，经营消费电商平台“羊小咩”及汽车汽车零售O2O平台“消费地图”，协助业务伙伴将商品及服务与终端消费者匹配。量化派的羊小咩平台自2020年11月起涵盖各式零售商品，如第三方市场供货商提供的消费电子产品、食品及饮料、家电、化妆品、珠宝、服装及个人日常护理用品，并通过在线购买将该等消费品与公司的羊小咩用户进行匹配。量化派自2022年4月经营汽车零售O2O平台消费地图，目前主要与汽车零售商合作吸引在线流量，使其能够在当地实体店线下购车，在较小程度上，消费地图亦可让消费者在在线购车。此外，量化派也为商业伙伴提供广告服务。2228.HK 晶泰控股 (+25.53%)消息面上，晶科能源近日宣佈，與晶泰科技簽署戰略合作協議，雙方將共同成立合資公司，推進基於AI技術的高通量鈣鈦礦疊層太陽能電池合作研發。此舉標誌着兩家正式開啓在鈣鈦礦疊層等下一代光伏技術領域的深度協同，旨在通過“AI+機器人”重塑光伏研發範式，加速顛覆性技術的研發與產業化進程。此外，晶泰控股公佈，建議發行28.66億元於2027年到期的零息可轉換債券，初始轉換價爲每股13.85港元，較1月7日收市價11.54港元溢價約20%，可悉數轉換爲2.07億股，佔擴大後股本約4.59%。所得款項擬用於提升公司國內及國際研發能力以及一站式解決方案提供能力；提升國內及國際商業化能力，並擴大業務發展及營銷團隊；透過興建廠房擴大國內及國際交付及研發能力；營運資金和一般公司用途。3696.HK 英矽智能 (+25.07%)2025年末，英矽智能登陆港交所，摘得“港股AI制药第一股”头衔，并以首日飙涨45.53%的姿态震撼市场。上市数日后，该公司宣布，与施维雅达成价值8.88亿美元的多年期抗肿瘤药物研发合作，剑指抗肿瘤领域“具有挑战性的靶点”。这一连串事件，再次将“人工智能如何颠覆传统药物研发”的议题推至聚光灯下。市场反应热烈。新年第一个完整周，英矽智能升25.07%。二、跌幅居前个股解析1918.HK 融创中国 (-11.72%)融创中国公布，去年累计合同销售金额约368.4亿元(人民币‧下同)，按年下跌21.85%；累计合同销售面积约145.3万平方米，按年减少35.74%；合同销售均价每平方米约25350元。单计去年12月，合同销售金额约29.5亿元，按年升68.57%；合同销售面积约27.2万平方米，按年增长97.1%；合同销售均价每平方米约10850元。6088.HK 鸿腾精密 (-11.35%)鸿腾精密公布，自昨日(1日)起选用替代门槛而非初始指定门槛，即无论何时在联交所上市的股份类别中由公众人士持有的部分均须达至少10亿元的市值及占发行人该类别已发行股份(不包括库存股份)总数的至少10%，以符合上市规则第13.32B条订明的最低公众持股量。考虑到公司的股权架构、过往交易流通量及整体情况，董事会认为选用替代门槛乃属恰当，因此符合公司及其股东的整体利益。1729.HK 汇聚科技 (-11.09%)汇聚科技（01729）发布公告，于2026年1月2日，该公司根据股份计划发行1万股。6616.HK 环球新材国际 (-10.26%)环球新材国际发布公告，认购协议所载的全部先决条件均已达成，本金总额 10亿港元的可换股债券发行于2026年1月6日完成。可换股债券自2026年1月6日起已于维也纳证券交易所营运的 Vienna MTF上市。本公司亦已取得联交所批准换股股份上市及买卖。","news_type":1,"symbols_score_info":{"02228":2,"09678":2,"01729":2,"01918":2,"02595":2,"03696":2,"09995":2,"02685":2,"06616":2,"06088":2}},"isVote":1,"tweetType":1,"viewCount":2,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}